Notably, a correlation between high TAPT1 expression and improved odds of survival was also detected when analyzing non-small cell lung cancer (NSCLC) patients, suggesting that TAPT1 may generally influence tumor progression. The gene discussed is TAPT1; the disease is non-small cell lung carcinoma.